(Q33165430)

English

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

scientific article

Statements

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial (English)
Joseph Ragaz
Zhong-Hua Wang
Zhong-Sheng Tong
Yue-Yin Pan
Yong-Mei Yin
Chang-Ping Wu
Ze-Fei Jiang
Xiao-Jia Wang
Dong-Geng Liu
Ji-Feng Feng
Jian-Feng Luo
Zhi-Min Shao

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit